The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients

This publication has 26 references indexed in Scilit:

• Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)
  Annals of Internal Medicine, 1993
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up
  JAMA, 1990
• Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
  JAMA, 1990
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
  BMJ, 1990
• Apolipoprotein A-I containing lipoproteins in coronary artery disease
  Atherosclerosis, 1987
• Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts
  JAMA, 1987
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  Journal of the American College of Cardiology, 1986
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
  JAMA, 1984